VX-702

• Target :

  Autophagy|||p38 MAPK

• Related Pathways :

  Autophagy|||MAPK

• Purity :

  >99.99%

• Bioactivity :

  VX-702 is a highly specific p38? MAPK inhibitor, 14-fold higher selectivity for the p38? than p38?. VX-702 is a small molecule investigational oral anti-cytokine therapy for treatment of inflammatory diseases, specifically rheumatoid arthritis (RA) .

• Smiles :

  NC(=O)N(c1ccc(C(N)=O)c(n1)-c1ccc(F)cc1F)c1c(F)cccc1F

• Molecular Formula :

  C19H12F4N4O2

• Molecular Weight :

  404.32

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C

• CAS Number :

  745833-23-2